Carla S. Capobianco

Medicine · Health Sciences

5h-index592citations16works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(6), Cancer Research and Treatments(5), Estrogen and related hormone effects(3), Cancer Mechanisms and Therapy(3), Neuropeptides and Animal Physiology(2)

Publications16 total

Combination of racotumomab immunotherapy with programmed death-1 blockade in a preclinical model of non-small cell lung cancer
Translational Lung Cancer Research·2025Open Access
Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy
Scientific Reports·2022· 21 citedOpen Access
Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization
Scientific Reports·2020· 23 citedOpen Access
Abstract 5983: p38 kinase acts as a negative regulator of recurrence after surgery in a mammary carcinoma model, through apoptosis induction and proliferation inhibition
Cancer Research·2020
Abstract 6232: Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization
Cancer Research·2020
Abstract 2649: Isolation and characterization of novel murine mammary cell line with dormant phenotype and identification of new potential targets by mass spectrometry
Cancer Research·2020
Abstract 6648: Racotumomab and PD-1 blockade combination exhibits an additive antitumor effect in a non-small cell lung cancer model
Cancer Research·2020· 1 cited
Drug Repurposing of β-blocker Propranolol in Osteosarcoma: Preclinical Antitumor Efficacy Alone or in Combination with Chemotherapy.
2020Open Access
Isolation and characterization of murine mammary cell lines with differentiated aggressive phenotype
Medicina-buenos Aires·2019
Abstract 78: p38 kinase is a negative regulator of tumorigenesis and recurrence after surgery in a mammary carcinoma model
Cancer Research·2018· 1 cited
Abstract 5118: Development of new alternative <i>in vivo</i> models to study early metastasic dissemination in breast cancer
Cancer Research·2018
Caracterización celular y molecular de la enfermedad mínima residual en cáncer
Conicet·2017Open Access
Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells
Frontiers in Oncology·2017· 32 citedOpen Access
CIGB-300, an anti-CK2 peptide, inhibits angiogenesis, tumor cell invasion and metastasis in lung cancer models
Lung Cancer·2016· 39 citedOpen Access
TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling
Nature Cell Biology·2013· 472 citedOpen Access
Abstract 5234: Microenvironmental signals dictate disseminated tumor cells (DTCs) fate through regulation of TGFβII and p38α
Cancer Research·2012· 3 cited

Frequent Co-authors

Daniel F. Alonso(11), Hernán G. Fariña(10), María Florencia Gottardo(8), Johanna E. Sidabra(7), Juan Garona(6), Julio A. Aguirre‐Ghiso(3), Paloma Bragado(2), Yeriel Estrada(2), Denis M. Schewe(2), Yasser Perera(2), Silvio E. Perea(2), Giselle V. Ripoll(2), Luisina M. Solernó(2), Natasha T. Sobol(2), Liliana Vásquez(2), Valeria I. Segatori(2), Cynthia A. Gulino(2), Selene Rojo(2), Gretel Magalí Ferreira(2), Mariano R. Gabri(2)